These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25554636)

  • 1. Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types.
    Panicker G; Rajbhandari I; Gurbaxani BM; Querec TD; Unger ER
    J Immunol Methods; 2015 Feb; 417():107-114. PubMed ID: 25554636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex immunoassay to measure antibody response to nine HPV vaccine types.
    Panicker G; Rajbhandari I; Pathak HN; Brady AM; Unger ER
    J Immunol Methods; 2021 Nov; 498():113136. PubMed ID: 34464605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.
    Robbins HA; Waterboer T; Porras C; Kemp TJ; Pawlita M; Rodriguez AC; Wacholder S; Gonzalez P; Schiller JT; Lowy DR; Esser M; Matys K; Poncelet S; Herrero R; Hildesheim A; Pinto LA; Safaeian M
    Hum Vaccin Immunother; 2014; 10(10):2965-74. PubMed ID: 25483632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18.
    Layman H; Rickert KW; Wilson S; Aksyuk AA; Dunty JM; Natrakul D; Swaminathan N; DelNagro CJ
    PLoS One; 2020; 15(3):e0229672. PubMed ID: 32214362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a VLP-based and GST-L1-based multiplex immunoassay to detect vaccine-induced HPV-specific antibodies in first-void urine.
    Pattyn J; Panicker G; Willhauck-Fleckenstein M; Van Keer S; Téblick L; Pieters Z; Tjalma WAA; Matheeussen V; Van Damme P; Waterboer T; Unger ER; Vorsters A
    J Med Virol; 2020 Dec; 92(12):3774-3783. PubMed ID: 32266996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial.
    Krajden M; Cook D; Yu A; Chow R; Mei W; McNeil S; Money D; Dionne M; Karunakaran KP; Palefsky JM; Dobson S; Ogilvie G; Petric M
    Clin Vaccine Immunol; 2011 Mar; 18(3):418-23. PubMed ID: 21248158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.
    Scherpenisse M; Schepp RM; Mollers M; Mooij SH; Meijer CJ; Berbers GA; van der Klis FR
    Clin Vaccine Immunol; 2013 Aug; 20(8):1329-32. PubMed ID: 23740920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.
    Safaeian M; Ghosh A; Porras C; Lin SW; Rodriguez AC; Schiffman M; Wacholder S; Kemp T; Gonzalez P; Wentzensen N; Esser M; Meuree A; Matys K; Quint W; van Doorn LJ; Sherman ME; Herrero R; Pinto LA; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1547-54. PubMed ID: 22752082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.
    Brown DR; Garland SM; Ferris DG; Joura E; Steben M; James M; Radley D; Vuocolo S; Garner EI; Haupt RM; Bryan JT
    Hum Vaccin; 2011 Feb; 7(2):230-8. PubMed ID: 21307649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11.
    Smith JF; Kowalski R; Esser MT; Brown MJ; Bryan JT
    Hum Vaccin; 2008; 4(2):134-42. PubMed ID: 18388490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.
    Krajden M; Cook D; Yu A; Chow R; Su Q; Mei W; McNeil S; Money D; Dionne M; Palefsky J; Karunakaran K; Kollmann T; Ogilvie G; Petric M; Dobson S
    Vaccine; 2014 Jan; 32(5):624-30. PubMed ID: 24055350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
    J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed serologic assay for nine anogenital human papillomavirus types.
    Opalka D; Matys K; Bojczuk P; Green T; Gesser R; Saah A; Haupt R; Dutko F; Esser MT
    Clin Vaccine Immunol; 2010 May; 17(5):818-27. PubMed ID: 20237197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.
    Brown D; Müller M; Sehr P; Pawlita M; Seitz H; Rubio I; Antonello J; Radley D; Roberts C; Saah A
    Vaccine; 2014 Oct; 32(44):5880-7. PubMed ID: 25148777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
    Villa LL; Ault KA; Giuliano AR; Costa RL; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson SE; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E
    Vaccine; 2006 Jul; 24(27-28):5571-83. PubMed ID: 16753240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.
    Roberts C; Green T; Hess E; Matys K; Brown MJ; Haupt RM; Luxembourg A; Vuocolo S; Saah A; Antonello J
    Hum Vaccin Immunother; 2014; 10(8):2168-74. PubMed ID: 25424920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.
    Zhao H; Lin ZJ; Huang SJ; Li J; Liu XH; Guo M; Zhang J; Xia NS; Pan HR; Wu T; Li CG
    Hum Vaccin Immunother; 2014; 10(3):740-6. PubMed ID: 24384608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.
    Olsson SE; Villa LL; Costa RL; Petta CA; Andrade RP; Malm C; Iversen OE; Høye J; Steinwall M; Riis-Johannessen G; Andersson-Ellstrom A; Elfgren K; von Krogh G; Lehtinen M; Paavonen J; Tamms GM; Giacoletti K; Lupinacci L; Esser MT; Vuocolo SC; Saah AJ; Barr E
    Vaccine; 2007 Jun; 25(26):4931-9. PubMed ID: 17499406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types.
    Nolan KM; Seaton B; Antonello J; Zhang Y; Cook L; Delfino K; Rubinstein LJ; Cheon K; Group T; Luxembourg A; Dubey S
    mSphere; 2023 Apr; 8(2):e0096221. PubMed ID: 36926984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.